NATURE’S SUNSHINE PRODUCTS, INC. Operating Expenses
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Operating Expenses of $65.09 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2013-05-09
- NATURE’S SUNSHINE PRODUCTS, INC. operating expenses for the quarter ending 2013-03-31 was $65.09M, a 8.55% increase year-over-year.
- NATURE’S SUNSHINE PRODUCTS, INC. operating expenses for the quarter ending 2012-03-31 was $59.97M.
- NATURE’S SUNSHINE PRODUCTS, INC. operating expenses for fiscal 2012 was $240.13M, a 7.01% decline from fiscal 2011.
- NATURE’S SUNSHINE PRODUCTS, INC. operating expenses for fiscal 2011 was $258.24M, a 3.55% increase from fiscal 2010.
- NATURE’S SUNSHINE PRODUCTS, INC. operating expenses for fiscal 2010 was $249.39M.
| Period end | Operating Expenses 3 month | Operating Expenses 12 month |
|---|---|---|
| 2013-03-31 | $65.09M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $240.13M 10-K · filed 2013-03-07 | |
| 2012-03-31 | $59.97M 10-Q · filed 2013-05-09 | |
| 2011-12-31 | $258.24M 10-K · filed 2013-03-07 | |
| 2010-12-31 | $249.39M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |